1. by Peter L. Turecek, Hans Peter Schwarz, and Bernd R. Binder
In vivo inhibition of low density lipoprotein receptor–related protein improves survival of factor VIII in the absence of von Willebrand factor
by Peter L. Turecek, Hans Peter Schwarz, and Bernd R. Binder
Blood
Volume 95(11):
June 1, 2000
©2000 by American Society of Hematology

2. Inhibition of LRP by RAP improves survival of infused human recombinant FVIII in vWf knockout mice.Animals were treated with 200 U/kg human rFVIII with and without preadministration of RAP (40 mg/kg).
Inhibition of LRP by RAP improves survival of infused human recombinant FVIII in vWf knockout mice.Animals were treated with 200 U/kg human rFVIII with and without preadministration of RAP (40 mg/kg). FVIII antigen (FVIII:Ag) was measured by an ELISA specific for human FVIII. Group means are shown ± SD.
Peter L. Turecek et al. Blood 2000;95:
©2000 by American Society of Hematology